Incidence of Restrictive Lung Disease Following Autologous Stem Cell Transplantation for High Risk Lymphoma
Serial monitoring of pulmonary function tests (PFT) following allogeneic hematopoietic cell transplants (HCT) is common, with both obstructive and restrictive lung defects well described. In contrast, serial monitoring of PFT post autologous HCT is less commonly performed, with the incidence of post-HCT lung disease ill-defined in this population. We now report the incidence of restrictive lung disease (RLD) in a series of autograft recipients undergoing transplantation for Hodgkin's (HL) or non-Hodgkin's lymphoma (NHL) at our center.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Matthew Whalen, Colin Hayes, Thomas Braun, Dawson Myers, John Magenau, John Maciejewski, Sarah Anand, Mary Mansour Riwes, Ghada Abusin, Mark T. Vander Lugt, Monalisa Ghosh, Attaphol Pawarode, Sung Choi, Michael Triebwasser, Gregory A. Yanik Tags: 145 Source Type: research
More News: Biology | Bone Graft | Hematology | Hodgkin's Disease | Lung Transplant | Lymphoma | Non-Hodgkin's Lymphoma | Stem Cell Therapy | Stem Cells | Transplants